dr allison felker
Allison Felker joined The National Perinatal Epidemiology Unit (NPEU) in April 2023 as a senior researcher for MBRRACE-UK.
Prior to her current position, Allison worked as a postdoctoral researcher at McMaster University (Canada) investigating the effect of herpes simplex virus on pregnancy outcomes. She then joined the Society of Obstetricians and Gynaecologists of Canada (SOGC) where she conducted evidence reviews and contributed to several research projects relating to perinatal mental health, substance use in pregnancy, and maternal mortality.
Allison received her PhD in Reproductive Biology from Queen’s University (Canada) with a thesis focussing on the regulation of uterine natural killer cells in early pregnancy. She received her BSc in Biomedical Sciences from the University of Waterloo (Canada).
Primary HSV-2 Infection in Early Pregnancy Results in Transplacental Viral Transmission and Dose-Dependent Adverse Pregnancy Outcomes in a Novel Mouse Model.
Felker AM. et al, (2021), Viruses, 13
Male fetal sex affects uteroplacental angiogenesis in growth restriction mouse model†.
Hebert JF. et al, (2021), Biol Reprod, 104, 924 - 934
Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice.
Wessels JM. et al, (2021), Sci Rep, 11
Curcumin Can Decrease Tissue Inflammation and the Severity of HSV-2 Infection in the Female Reproductive Mucosa.
Vitali D. et al, (2020), Int J Mol Sci, 21
Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice.
Wessels JM. et al, (2019), Dis Model Mech, 12